» Articles » PMID: 20946654

Disease-specific Definitions of Vitamin D Deficiency Need to Be Established in Autoimmune and Non-autoimmune Chronic Diseases: a Retrospective Comparison of Three Chronic Diseases

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2010 Oct 16
PMID 20946654
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: We compared the odds of vitamin D deficiency in three chronic diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and type 2 diabetes (T2DM), adjusting for medications, demographics, and laboratory parameters, common to all three diseases. We also designed multivariate models to determine whether different factors are associated with vitamin D deficiency in different racial/ethnic groups.

Methods: We identified all patients with non-overlapping diagnoses of SLE, RA, and T2DM, with 25-hydroxyvitamin D (25OHD) levels measured between 2000 and 2009. Vitamin D deficiency was defined as 25OHD levels <20 ng/ml, based on previously established definitions. Race/ethnicity was analyzed as African-American non-Hispanic (African-American), Hispanic non-African-American (Hispanic), and Other based on self report.

Results: We included 3,914 patients in the final analysis: 123 SLE, 100 RA, and 3,691 T2DM. Among African-Americans the frequency of vitamin D deficiency was 59% in SLE, 47% in RA, and 67% in T2DM. Among Hispanics the frequency of vitamin D deficiency was 67% in SLE, 50% in RA, and 59% in T2DM. Compared with the SLE group, the adjusted odds ratio of vitamin D deficiency was 1.1, 95% CI (0.62, 2.1) in the RA group, and 2.0, 95% CI (1.3, 3.1) in the T2DM group. In the multivariate analysis, older age, higher serum calcium and bisphosphonate therapy were associated with a lower odds of vitamin D deficiency in all three racial/ethnic groups: 1,330 African-American, 1,257 Hispanic, and 1,100 Other. T2DM, serum creatinine, and vitamin D supplementation were associated with vitamin D deficiency in some, but not all, racial/ethnic groups.

Conclusions: Vitamin D deficiency is highly prevalent in our patients with SLE, RA, and T2DM. While the odds of vitamin D deficiency are similar in RA and SLE patients in a multivariate analysis, T2DM patients have much higher odds of being vitamin D deficient. Different demographic and laboratory factors may be associated with vitamin D deficiency within different racial/ethnic groups. Therefore, disease-specific and race/ethnicity-specific definitions of vitamin D deficiency need to be established in future studies in order to define goals of vitamin D replacement in patients with autoimmune and non-autoimmune chronic diseases.

Citing Articles

Prevalence of vitamin D deficiency in patients with autoimmune rheumatic diseases visiting the rheumatology clinic at the National Referral Hospital, Bhutan.

Dorji S, Yangchen S, Chuki P SAGE Open Med. 2024; 12:20503121231223313.

PMID: 38249953 PMC: 10798065. DOI: 10.1177/20503121231223313.


Normalization of Vitamin D Serum Levels in Patients with Type Two Diabetes Mellitus Reduces Levels of Branched Chain Amino Acids.

Alfaqih M, Melhem N, Khabour O, Al-Dwairi A, Elsalem L, Alsaqer T Medicina (Kaunas). 2022; 58(9).

PMID: 36143944 PMC: 9505541. DOI: 10.3390/medicina58091267.


No Association between 25-Hydroxyvitamin D and Insulin Resistance or Thyroid Hormone Concentrations in a Romanian Observational Study.

Stoica R, Guja C, Pantea-Stoian A, Staden R, Popa-Tudor I, Stefan S Medicina (Kaunas). 2021; 57(1).

PMID: 33396784 PMC: 7824327. DOI: 10.3390/medicina57010025.


Analysis of Association between Vitamin D Deficiency and Insulin Resistance.

Szymczak-Pajor I, Sliwinska A Nutrients. 2019; 11(4).

PMID: 30959886 PMC: 6520736. DOI: 10.3390/nu11040794.


Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.

Garbossa S, Folli F Rev Endocr Metab Disord. 2017; 18(2):243-258.

PMID: 28409320 DOI: 10.1007/s11154-017-9423-2.


References
1.
Bellin E, Fletcher D, Geberer N, Islam S, Srivastava N . Democratizing information creation from health care data for quality improvement, research, and education-the Montefiore Medical Center Experience. Acad Med. 2010; 85(8):1362-8. DOI: 10.1097/ACM.0b013e3181df0f3b. View

2.
Muller K, Kriegbaum N, Baslund B, Sorensen O, Thymann M, Bentzen K . Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol. 1995; 14(4):397-400. DOI: 10.1007/BF02207671. View

3.
Freedman B, Wagenknecht L, Hairston K, Bowden D, Carr J, Hightower R . Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab. 2010; 95(3):1076-83. PMC: 2841532. DOI: 10.1210/jc.2009-1797. View

4.
Cheng S, Massaro J, Fox C, Larson M, Keyes M, McCabe E . Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2009; 59(1):242-8. PMC: 2797928. DOI: 10.2337/db09-1011. View

5.
. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006; 30 Suppl 1:S42-7. DOI: 10.2337/dc07-S042. View